RPTX is currently covered by 5 analysts with average potential upside of $13.88 (65.23%) backed by 5 price targets and 23 ratings. Documented since 14-Jul-2020. Analyst's average stock valuation to be materialised ratio is 23.33% with an average time for price targets to be met of 46.4 days.
Most recent stock forecast was given by ROBERT BURNS from HCWAINWRIGHT on 17-Mar-2023.
Highest price target for RPTX is 34, Lowest price target is 9, average price target is 21.5.
Currently, out of the existing stock ratings of RPTX - 18 which are a Buy (94.74%), 1 which are a Hold (5.26%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
25
$15.4 (160.42%)
25
11 days ago
0/5 (0%)
$18.47 (102.78%)
Hold
14
$4.4 (45.83%)
15
1 months 1 days ago
2/6 (33.33%)
$8.64 (34.73%)
85
Buy
30
$20.4 (212.50%)
25
9 months 26 days ago
2/4 (50%)
$14.19 (89.75%)
141
Buy
11
$1.4 (14.58%)
47
11 months 16 days ago
1/3 (33.33%)
$13.43 (48.83%)
6
Buy
44
$27.94 (173.97%)
46
1 years 4 months 18 days ago
0/2 (0%)
$14.68 (50.06%)
What is RPTX(Repare Therapeutics Inc.) average time for price targets to be met?
Which analyst has the current highest performing score on RPTX(Repare Therapeutics Inc.) with a proven track record?
